i3 BioMedical Inc.
For the First Time Scientific Data From a Certified Canadian Laboratory Answers This Fundamental Question.
MIRABEL, Quebec, Canada, March 23, 2021 (GLOBE NEWSWIRE) -- i3 Biomedical inc., a medical device corporation, releases today the comparative results of Live viruses Filtration performances of numerous Medical Face masks and Respirators in the tables included. For a comprehensive understanding, the results are rendered in the form of number of viruses inhaled per Minute per Mask/Respirator based on the average volume of air of 7 liter per minute required by humans. The scientific data is the result of advanced testing executed by GAP EnviroMicrobial Services Ltd., an independent Canadian ISO certified laboratory.
All Procedure masks, Medical Masks and Respirators (further referred to as "Masks") following the European and/or American regulatory standards are not required to be tested against live viruses, but only against either a solid particle (example: salt particles) or against bacteria (which are approximately 100 times bigger in size than viruses).
The only regulated standards currently used in the Americas and in Europe that include testing the assessment of the filtration performances of microbes are respectively the North American ASTM 2100 and the European EN14683 Bacterial Filtration Efficiency (BFE). While it is not a government requirement, the substitution of the Bacteria for a Live Virus to test Viral Filtration Efficiency (VFE) is accepted. These standardized testing protocols require a concentration of 10^5 viruses per liter of air for only a 2-minute testing time, hence providing the filtration performance of "Masks" in use for 2 minutes only. GAP EnviroMicrobial Services Ltd. was mandated to test the (VFE) following the same protocols but for a testing time of 30 minutes at the NIOSH1 recommended air speed of 85 LPM, on various masks (Procedure masks, Surgical/Medical masks ASTM Level 3, CE Type IIR, KN 95 masks, N95 masks and FFP2 masks). The above-mentioned testing is done on the filter materials only of the masks as per protocol requirements.
For reference, a single cough from an infected subject can release an average of 4,914,600 aerosolized viral particles2. Find the answer to: Does your mask/respirator filter live Viruses in the Tables included.
For more information on the TrioMed Active face masks, visit www.triomed.com or send an email to triomed@triomed.com
About i3 BioMedical Inc: i3 BioMedical is a Canadian medical device corporation, focused on the development and manufacturing of novel antimicrobial products incorporating the TrioMed Active Technology.
About GAP EnviroMicrobial Services Ltd.: GAP EnviroMicrobial Services Ltd. (GAP), established in 1996, is ISO/IEC 17025:2005 compliant with accreditation by the Canadian Association for Laboratory Accreditation (CALA), CALA accreditation is recognized by almost 60 accrediting bodies in 40 countries around the world.
1 National Institute for Occupational Safety and Health
2 Lee, J., Yoo, D., Ryu, S., Ham, S., Lee, K., Yeo, M., Min, K. and Yoon, C. (2019). Quantity, Size Distribution, and Characteristics of Cough-generated Aerosol Produced by Patients with an Upper Respiratory Tract Infection. Aerosol Air Qual. Res. 19: 840-853. https://doi.org/10.4209/aaqr.2018.01.0031
Photos:
https://www.globenewswire.com/NewsRoom/AttachmentNg/6b7816c8-e759-424c-883e-08620c20283e
https://www.globenewswire.com/NewsRoom/AttachmentNg/ca1644fd-d4c7-464d-b277-e83e986707b7
https://www.globenewswire.com/NewsRoom/AttachmentNg/8ce6b02b-2bbf-4d04-a8a3-2d37eaa0d15f
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom